Hepatitis B [Working Title]最新文献

筛选
英文 中文
Establishment of a Mouse Model of Chronic Hepatitis B Virus Infection and Purification of Hepatic Parenchymal and Non-Parenchymal Cells 慢性乙型肝炎病毒感染小鼠模型的建立及肝实质细胞和非实质细胞的纯化
Hepatitis B [Working Title] Pub Date : 2021-09-05 DOI: 10.5772/intechopen.99939
Yan Yan, Chantsalmaa Davgadorj
{"title":"Establishment of a Mouse Model of Chronic Hepatitis B Virus Infection and Purification of Hepatic Parenchymal and Non-Parenchymal Cells","authors":"Yan Yan, Chantsalmaa Davgadorj","doi":"10.5772/intechopen.99939","DOIUrl":"https://doi.org/10.5772/intechopen.99939","url":null,"abstract":"The use of replication-competent hepatitis B virus (HBV) DNA to construct a mouse model will help explore antiviral treatment strategies for more than 240 million patients infected with HBV worldwide. Eradication of chronic HBV infection can effectively block the adverse consequences of HBV-induced hepatic cirrhosis, failure and carcinoma. The core reason that HBV is difficult to eradicate is that most of infected people develop chronic HBV infection due to the establishment of immune tolerance. Here, we introduce a mouse model of adeno-associated virus (AAV)-HBV transfection, which produces HBV surface antigen (HBsAg) that can be maintained for more than 6 months. During virus replication, intermediates, transcripts, and proteins can be detected in peripheral blood. At the same time, the prerequisite for studying liver disease formation and immunotherapy through in vitro experiments is to isolate hepatic subgroup cells. Here, we describe a cell sorting method based on liberase perfusion technology combined with low-speed centrifugation and magnetic bead antibody labeling to purify hepatic parenchymal cells (PCs) and non-parenchymal cells (NPCs) step by step from murine liver, such as hepatic sinusoidal endothelial cells (LSECs) and Kupffer cells (KCs), which will help accelerate the study of the genetic and clearance mechanistic of chronic HBV infection.","PeriodicalId":220827,"journal":{"name":"Hepatitis B [Working Title]","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131353489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Level of Antibody Response against Hepatitis B Virus after Vaccination and Seroprevalence of HBV in Children Addis Ababa, Ethiopia 亚的斯亚贝巴,埃塞俄比亚儿童接种乙肝疫苗后抗乙肝病毒抗体反应水平和血清HBV阳性率
Hepatitis B [Working Title] Pub Date : 2021-09-05 DOI: 10.5772/intechopen.99970
H. Biazin, Seifegebriel Teshome
{"title":"Level of Antibody Response against Hepatitis B Virus after Vaccination and Seroprevalence of HBV in Children Addis Ababa, Ethiopia","authors":"H. Biazin, Seifegebriel Teshome","doi":"10.5772/intechopen.99970","DOIUrl":"https://doi.org/10.5772/intechopen.99970","url":null,"abstract":"Approximately 2 billion people worldwide are infected with HBV and more than 240 million are chronic carriers. The World Health Organization officially launched the introduction of the hepatitis B vaccine for children in 1980. Since then, different countries have determined the level of response to the vaccine. Since the introduction of the vaccine in Ethiopia in 2007, there have been few studies evaluating the antibody response to the HBV vaccine. Therefore, the purpose of this study is to determine the HBV antibody response after hepatitis B vaccination and to evaluate the HBV seroprevalence of children in Addis Ababa, Ethiopia. A cross-sectional study was conducted using a multistage probability sampling technique. Four hundred and fifty children between the ages of five and eight living in Addis Ababa were enrolled. Socio-demographic characteristics were obtained through a structured questionnaire and three to four ml of blood was collected from each child. ELISA was performed to determine antibody levels against HBV. The average age is seven + one (SD) years. Anti-HBs were detected in 54.3% (208/450) of children, and girls 98 (54.7%) had a slightly higher level of protection than boys 110 did (53.9%). The overall coverage rate of the vaccine in this study was 85.1%. The proportion of children with protective levels (> 10 mIU / ml of anti-HBs antibodies) decreased with increasing age of the children: 5, 6, 7 and 8 years were 52.6%, 60%, 43.5% and 37.1%, respectively. The seroprevalence rate for HBsAg is 0.4% and the seroprevalence rate for anti-HBc is 5.6%. Age and antibody response level were negatively correlated (p = 0.001), while gender and history of HBV infection were not significantly correlated. Age was also significantly correlated with anti-HBc seropositivity (p = 0.003). HBV vaccine coverage for children is high, but the antibody response to the vaccine appears to be low. The seropositivity rate for the virus is also very low. Low levels of response to the vaccine should be a problem. For unresponsive children, revaccination or booster doses should be considered. More research needs to be done.","PeriodicalId":220827,"journal":{"name":"Hepatitis B [Working Title]","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121918115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maternal Hepatitis Infections: Determining Seroprevalence of Hepatitis B and C Virus Infections and Associated Risk Factors among Healthy Mothers in Addis Ababa, Ethiopia 孕产妇肝炎感染:测定埃塞俄比亚亚的斯亚贝巴健康母亲中乙型和丙型肝炎病毒感染的血清流行率及相关危险因素
Hepatitis B [Working Title] Pub Date : 2021-08-04 DOI: 10.5772/intechopen.99117
H. Kebede, Seifegebriel Teshome
{"title":"Maternal Hepatitis Infections: Determining Seroprevalence of Hepatitis B and C Virus Infections and Associated Risk Factors among Healthy Mothers in Addis Ababa, Ethiopia","authors":"H. Kebede, Seifegebriel Teshome","doi":"10.5772/intechopen.99117","DOIUrl":"https://doi.org/10.5772/intechopen.99117","url":null,"abstract":"Introduction: Viral hepatitis is a global public health problem affecting millions of people every year, causing disability and death. Hepatitis B (HBV) and hepatitis C (HCV) viruses spread horizontally, mainly through sexual contact and contaminated needles, and vertically. Both cause considerable morbidity and mortality worldwide. Maternal infection is a risk factor for vertical transmission. Objective: To determine the seroprevalence of HBsAg and anti-HCV antibody among non-pregnant, apparently healthy mothers and to identify potential risk factors associated with HBV or HCV infection. Methods: A community based cross sectional study was conducted on 454 apparently healthy women, in Addis Ababa, Ethiopia from May 2016 to June 2017. A systematic random sampling method was used to recruit participants. Result: A total of 454 mothers were enrolled. Seroprevalence of HBsAg and HCV was found to be 3.7% and 2.0%, respectively. HBc antibody was detected in 36.3% of the mothers. None of the participants was co-infected with both viruses. Previous history of liver disease, history of jaundice, HIV infection, and family history of liver disease were significantly associated with HBV infection. Marital status, caring for hepatitis patients, and a history of liver disease were factors significantly associated with HCV infection. Conclusion: Apparently, healthy mothers in Addis Ababa had intermediate level of endemicity for hepatitis B and C infections Routine screening and vaccination of high-risk reproductive mothers against HBV is advisable. Emphasis should be given to health education and promotion of infection control practices. Population based studies are strongly recommended to help monitor disease transmission patterns and to design evidence-based interventions against the spread of hepatitis infections in Ethiopia.","PeriodicalId":220827,"journal":{"name":"Hepatitis B [Working Title]","volume":"38 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133243981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信